omega-n-methylarginine has been researched along with pyruvic acid in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pyruvic acid) | Trials (pyruvic acid) | Recent Studies (post-2010) (pyruvic acid) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 8,310 | 169 | 2,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JC; Kahn, AM; Lichtenberg, DS; Seidel, CL; Song, T; Zhang, S | 1 |
Ning, J; Titheradge, MA; Wallington, J | 1 |
2 other study(ies) available for omega-n-methylarginine and pyruvic acid
Article | Year |
---|---|
Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential.
Topics: Aerobiosis; Animals; Cells, Cultured; Dogs; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Female; Glycolysis; Guanylate Cyclase; Immunoblotting; Insulin; Lactic Acid; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxidation-Reduction; Penicillamine; Pyruvic Acid; S-Nitroso-N-Acetylpenicillamine | 2000 |
The control of hepatic glycogen metabolism in an in vitro model of sepsis.
Topics: Adenylate Kinase; Animals; Cytokines; Disease Models, Animal; Glucose; Glucose-6-Phosphate; Glycogen Phosphorylase; Glycogen Synthase; Glycogen Synthase Kinase 3; Glycogenolysis; Humans; Lactic Acid; Lipopolysaccharides; Liver; Liver Glycogen; Male; omega-N-Methylarginine; Phosphorylation; Protein Kinases; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Sepsis; Uridine Diphosphate Glucose | 2008 |